RK

Rama Krishana Prasad Gulla Palli

Active Director Designated Partner DIN 11194184
DIN 11194184 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rama Krishana Prasad Gulla Palli

Data last updated:

Rama Krishana Prasad Gulla Palli is a Designated Partner at Prosaps Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11194184
Primary Designation Designated Partner
Industry Pharma
First Appointment 14 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Jul 20252025Active

Board colleagues of Rama Krishana Prasad Gulla Palli

NameDINCompanyDesignation
Naveen Babu Teegala11194185Prosaps Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Prosaps Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Rama Krishana Prasad Gulla Palli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Krishana Prasad Gulla Palli

Rama Krishana Prasad Gulla Palli currently holds 1 directorship: Prosaps Pharmaceuticals Llp (Designated Partner, since 14 Jul 2025).

Rama Krishana Prasad Gulla Palli was first appointed on 14 Jul 2025 as Designated Partner at Prosaps Pharmaceuticals Llp.

The current boards of Rama Krishana Prasad Gulla Palli's companies include Naveen Babu Teegala (Prosaps Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available